Hugel Inc
145020
Company Profile
Business description
Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.
Contact
61-20, Sinbuk-ro, Sinbuk-eup
ChuncheonGangwon24206
KORT: +82 332553882
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
625
Stocks News & Analysis
stocks
This ASX miner is the cheapest in our iron ore coverage
High debt levels and low commodity prices were a concern, but agreed sell-downs and a ramp-up of key operations should help.
stocks
Apple names new CEO as Tim Cook steps aside after 15 years
John Ternus, Apple’s hardware chief, will take up the role in September.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,074.40 | 50.80 | -0.56% |
| CAC 40 | 8,188.81 | 46.90 | -0.57% |
| DAX 40 | 24,245.88 | 24.99 | -0.10% |
| Dow JONES (US) | 49,566.77 | 417.39 | 0.85% |
| FTSE 100 | 10,490.86 | 7.23 | -0.07% |
| HKSE | 26,163.24 | 324.24 | -1.22% |
| NASDAQ | 24,563.24 | 303.28 | 1.25% |
| Nikkei 225 | 59,585.86 | 236.69 | 0.40% |
| NZX 50 Index | 12,945.60 | 13.27 | 0.10% |
| S&P 500 | 7,128.81 | 64.80 | 0.92% |
| S&P/ASX 200 | 8,843.60 | 53.20 | -0.60% |
| SSE Composite Index | 4,106.26 | 21.18 | 0.52% |